foundation
Christopher & Dana Reeve Foundation
www.christopherreeve.org (opens in a new tab)6 openCatalog updated
Open programs6
Pre-Clinical Research Request for Applications
The Christopher & Dana Reeve Foundation supports 1–2 years of pre-clinical, non-human research advancing new or repurposed drugs, biologics, and medical devices for neuroprotection, regeneration, and plasticity in spinal cord injury.
- Deadline
- Not listed
- Amount
- $250,000
Pre-Clinical Research Request for Applications
The Christopher & Dana Reeve Foundation, in partnership with Spinal Research, funds 1–2 years of preclinical research on new or repurposed drugs, biologics, and medical devices for spinal cord injury neuroprotection, regeneration, and plasticity at the pre-IND or pre-IDE stage.
- Deadline
- Not listed
- Amount
- $250,000
Pre-Clinical Research RFA - Christopher & Dana Reeve Foundation
The Christopher & Dana Reeve Foundation, in partnership with Spinal Research, solicits pre‑clinical (non‑human) research to advance new or repurposed drugs, biologics, and devices for neuroprotection, regeneration, and plasticity in spinal cord injury at the pre‑IND/pre‑IDE development stage (excluding full drug screens, IND/IDE‑enabling studies, and clinical trials).
- Deadline
- Not listed
- Amount
- $250,000
Pre-clinical RFA Grants
The Christopher & Dana Reeve Foundation, in partnership with Spinal Research (ISRT), supports pre-clinical translational research in traumatic spinal cord injury to advance therapies toward pre-IND or pre-IDE development.
- Deadline
- Not listed
- Amount
- $250,000
Pre-clinical RFA Grants
The Christopher & Dana Reeve Foundation, in partnership with Spinal Research (ISRT), supports preclinical translational research in traumatic spinal cord injury to advance drugs, biologics, gene therapies, and medical devices toward pre-IND or pre-IDE development.
- Deadline
- Not listed
- Amount
- $250,000
Pre-clinical RFA Grants (pre-IND / pre-IDE translational research in traumatic spinal cord injury)
The Christopher & Dana Reeve Foundation, in partnership with Spinal Research (ISRT), will launch a pre‑clinical RFA (opening Q2 2024) to fund translational pre‑IND/pre‑IDE studies that de‑risk therapeutics and devices for traumatic spinal cord injury, emphasizing neuroprotection, regeneration and plasticity.
- Deadline
- Not listed
- Amount
- $250,000
Program details are the catalog's own fields as FundFit holds them: title, category, deadline, and amount. For the full listing and eligibility, follow the funder's site.